As filed with the Securities and Exchange Commission on March 12, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Upstream Bio, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
38-4187694 |
(State or other jurisdiction of |
(I.R.S. employer |
890 Winter Street, Suite 200 Waltham, MA (Address of principal executive offices) |
02451 (Zip Code) |
Upstream Bio, Inc. 2024 Stock Option and Incentive Plan
(Full title of the plan)
E. Rand Sutherland, M.D.
Chief Executive Officer
Upstream Bio, Inc.
890 Winter Street, Suite 200
Waltham, MA 02451
(Name and address of agent for service)
(781) 208-2466
(Telephone number, including area code, of agent for service)
Copies to:
Gabriela Morales-Rivera
William D. Collins
Kathryn W. Clerici
Goodwin Procter LLP
100 Northern Avenue
Boston, Massachusetts 02210
(617) 570-1000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ |
|
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
Pursuant to General Instruction E of Form S-8, Upstream Bio, Inc. (the “Registrant”) is filing this registration statement with the U.S. Securities and Exchange Commission (the “Commission”) to register 2,680,169 additional shares of the Registrant’s common stock, par value $0.001 per share (“Common Stock”), available for issuance under the Registrant’s 2024 Stock Option and Incentive Plan (the “Plan”), pursuant to the evergreen provisions of the Plan.
This Registration Statement incorporates by reference the contents of the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on October 11, 2024 (File No. 333-282614) (the “Earlier Registration Statement”) related to the Plan, except to the extent supplemented, amended or superseded by the information set forth herein. Only those items of Form S-8 containing new information not contained in the Earlier Registration Statement are presented herein.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
The exhibits to this Registration Statement are listed in the Exhibit Index attached hereto and incorporated by reference herein.
EXHIBIT INDEX
|
|
|
Exhibit |
|
Description |
|
|
|
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
|
5.1* |
|
|
|
|
|
23.1* |
|
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm. |
|
|
|
23.2* |
|
|
|
|
|
24.1* |
|
|
|
|
|
99.1 |
|
|
|
|
|
107* |
|
* Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Waltham, Massachusetts, on this 12th day of March, 2025.
UPSTREAM BIO, INC. |
||
By: |
|
/s/ E. Rand Sutherland |
|
|
Name: E. Rand Sutherland, M.D. Title: Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
Each individual whose signature appears below hereby constitutes and appoints each of E. Rand Sutherland, M.D. and Michael Paul Gray, M.B.A. as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
Name |
Title |
Date |
/s/ E. Rand Sutherland |
Chief Executive Officer and (Principal Executive Officer) |
March 12, 2025 |
E. Rand Sutherland, M.D. |
||
/s/ Michael Paul Gray |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
March 12, 2025 |
Michael Paul Gray, M.B.A. |
||
/s/ Ronald C. Renaud, Jr. |
Director and Chairman |
March 12, 2025 |
Ronald C. Renaud, Jr., M.B.A. |
||
/s/ Daniella Beckman |
Director |
March 12, 2025 |
Daniella Beckman |
||
/s/ Erez Chimovits |
Director |
March 12, 2025 |
Erez Chimovits, M.B.A., M.Sc. |
||
/s/ H. Edward Fleming, Jr. |
Director |
March 12, 2025 |
H. Edward Fleming, Jr., M.D. |
||
/s/ Liam Ratcliffe |
Director |
March 12, 2025 |
Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A. |
||
/s/ Marcella Kuhlman Ruddy |
Director |
March 12, 2025 |
Marcella Kuhlman Ruddy, M.D., M.S.
|